In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi sits down with Rachel Ellingson, chief strategy and corporate development officer at Solventum, recorded live at DeviceTalks Minnesota. Ellingson shares a rare perspective on leading medical device companies through major transitions, drawing on her experience at Zimmer Biomet during the ZimVie spinout and now at the helm of a business spun out from 3M Healthcare. She compares the two experiences and outlines what’s ahead for Solventum.

In our Future of MedTech Opportunities (FOMO) segment, Kayleen Brown speaks with Athar Mirza, VP of global infusion systems at Baxter International, about Baxter’s evolving role in connected health.

This episode is brought to you by Protolabs, https://www.protolabs.com.

Chris Newmarker and Sean Whooley break down the latest Newmarker’s Newsmakers, featuring headlines from Science, Olympus, Johnson & Johnson, and Stryker. Plus, Whooley shares insights from the American Diabetes Association meeting in Chicago, highlighting cutting-edge diabetes tech.

Thanks for tuning in to the DeviceTalks Weekly Podcast.

Enjoy this podcast? Follow DeviceTalks Weekly all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Ellingson Shares Solventum’s Next Steps, Baxter’s Mirza on its Connected Future, Wrap up of ADA

DeviceTalks Podcast Network

Ellingson Shares Solventum’s Next Steps, Baxter’s Mirza on its Connected Future, Wrap up of ADA